- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Optimal Lymphadenectomy for Patients with Noncurative Resection after Endoscopic Submucosal Dissection for Early Gastric Cancer Using the eCura System
-
- Hamai Kenta
- Department of General Surgery, Kurashiki Central Hospital
-
- Nagahisa Yoshio
- Department of General Surgery, Kurashiki Central Hospital
-
- Muto Jun
- Department of General Surgery, Kurashiki Central Hospital
-
- Hashida Kazuki
- Department of General Surgery, Kurashiki Central Hospital
-
- Yokota Mitsuru
- Department of General Surgery, Kurashiki Central Hospital
-
- Inamura Yukio
- Department of General Surgery, Kurashiki Central Hospital
-
- Yamaguchi Kazushige
- Department of General Surgery, Kurashiki Central Hospital
-
- Okabe Michio
- Department of General Surgery, Kurashiki Central Hospital
-
- Kitagawa Hirohisa
- Department of General Surgery, Kurashiki Central Hospital
-
- Kawamoto Kazuyuki
- Department of General Surgery, Kurashiki Central Hospital
Bibliographic Information
- Other Title
-
- eCura systemを用いた早期胃癌ESD非治癒切除病変に対する至適リンパ節郭清の検討
Search this article
Description
<p>Purpose: This study was designed to evaluate optimal lymphadenectomy for patients with noncurative resection after endoscopic submucosal dissection (ESD) for early gastric cancer using the eCura system. Methods: We examined 80 patients who underwent additional surgical resection for noncurative resection after ESD for early gastric cancer between January 2013 and February 2020. For comparison, we also examined 54 patients who underwent initial surgical resection for small advanced gastric cancer (<30 mm) with no lymph node metastases clinically, who were not indicated for ESD, during the same period. All patients were classified into three groups by risk level according to the eCura system, and the rate of lymph node metastasis was calculated in each group. Results: In the 80 patients treated with ESD, the median age was 71 years (40–90 years), 73 were men, the median follow-up period was 31 months (0–82 months), the rate of undifferentiated carcinoma was 23.8% (19 patients), and the rate of lymph node metastasis in each group was low risk, 4.0% (1/25 patients); intermediate risk, 11.1% (4/36); and high risk, 26.3% (5/19). One patient in the high risk group underwent D1 lymphadenectomy alone because of a comorbidity and died of recurrence of lymph node metastasis 3 months after additional surgical resection. The recurrence sites were lymph node stations 8a and 12a, which would have been dissected if D2 lymphadenectomy had been performed. In the 54 patients who did not undergo ESD, the rate of lymph node metastasis of 20.4% (11 patients) was higher than that in the high risk group. Conclusion: Patients with noncurative resection after ESD for early gastric cancer who are in the high risk group in the eCura system are more likely to have lymph node metastasis, and adequate lymphadenectomy including D2 lymphadenectomy should be considered for these patients.</p>
Journal
-
- The Japanese Journal of Gastroenterological Surgery
-
The Japanese Journal of Gastroenterological Surgery 55 (5), 297-301, 2022-05-01
The Japanese Society of Gastroenterological Surgery
- Tweet
Details 詳細情報について
-
- CRID
- 1390010765215284480
-
- ISSN
- 13489372
- 03869768
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- OpenAIRE
-
- Abstract License Flag
- Disallowed